BCRX β€” BIOCRYST PHARMACEUTICALS INC

Ownership history in WEALTH ENHANCEMENT ADVISORY SERVICES, LLC  Β·  10 quarters on record

AI Ownership Summary

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC reported BIOCRYST PHARMACEUTICALS INC (BCRX) in 10 quarterly 13F filings from 2024 Q1 through 2026 Q1. The latest visible filing shows BCRX at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this BCRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was WEALTH ENHANCEMENT ADVISORY SERVICES, LLC's position in BIOCRYST PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

BCRX was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How WEALTH ENHANCEMENT ADVISORY SERVICES, LLC held BCRX β€” position size vs. price
% of Fund (quarterly)    BCRX price (quarter-end, indexed to 100)
πŸ“‹ Quarterly Holdings History 9 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 12,322 -3,696 -23.1% 0.00% $111K 2026-04-08 $9.78
2025 Q4 REDUCED 16,018 -5,806 -26.6% 0.00% $121K 2026-01-08 $7.62
2025 Q3 REDUCED 21,824 -15,942 -42.2% 0.00% $152K 2025-10-29 $7.31
2025 Q2 ADDED 37,766 +95 +0.3% 0.00% $338K 2025-07-10 $8.88
2025 Q1 ADDED 37,671 +20,114 +114.6% 0.00% $283K 2025-04-16 $7.22
2024 Q4 ADDED 17,557 +213 +1.2% 0.00% $133K 2025-01-10 $7.67
2024 Q3 ADDED 17,344 +5,340 +44.5% 0.00% $132K 2024-10-24 $8.18
2024 Q2 ADDED 12,004 +743 +6.6% 0.00% $74K 2024-07-16 $7.63
2024 Q1 REDUCED 11,261 -1,293 -10.3% 0.00% $57K 2024-04-15 $4.67
1 older quarter hidden  β€”  Sign in free or upgrade to Premium to see full history

FAQ About WEALTH ENHANCEMENT ADVISORY SERVICES, LLC and BCRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has WEALTH ENHANCEMENT ADVISORY SERVICES, LLC reported owning BCRX?

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC reported BCRX across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported BCRX position in WEALTH ENHANCEMENT ADVISORY SERVICES, LLC's portfolio?

The largest reported portfolio weight for BCRX was 0.00% in 2025 Q2.

What is the latest reported BCRX position on this page?

The most recent filing on this page is 2026 Q1, when WEALTH ENHANCEMENT ADVISORY SERVICES, LLC reported 12,322 shares, equal to 0.00% of portfolio, with an estimated market value of $111K.

What does the chart on this BCRX ownership page compare?

The chart compares WEALTH ENHANCEMENT ADVISORY SERVICES, LLC's quarterly BCRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to WEALTH ENHANCEMENT ADVISORY SERVICES, LLC Holdings